Coronary artery bypass graft (CABG) is a surgical procedure used in treating patients with cardiovascular disorders. It is one of the methods used to unclog obstructions to the heart. These obstructions are plaque within coronary arteries due to cholesterol and unwanted lipids. It is also known as coronary artery bypass surgery. CABG remains popular due to development of minimal invasive techniques like the minimally-invasive direct CABG (MIDCAB). The globally increasing geriatric populace which is susceptible to cardiovascular disorders (CVDs) is anticipated to drive the bypass surgery graft market.
CABG is performed on 75% cases of patients with sudden cardiac arrest. Developments in CABG have led to endoscopic computer (robotics)-assisted CABG (C-CAB), full-sternotomy “off-pump” CABG (OPCAB), and port-access CABG (P-CAB). OPCAB techniques enjoyed a 60% approval rate in Japan, China, and India. Coronary artery bypass surgery enjoyed a longer survival rate in 80% of patients with stage 3 chronic kidney disease (CKD), according to a study by Toronto General Hospital.
Innovations in the market have led to the development of advanced devices like heart positioners which facilitate during surgery. For instance, MAQUET Holdings launched the HEARTSTRING III proximal system to aid surgeons during OPCAB. This device reduces the reliance on occlusion clamps to perform saphenous or radial artery grafts. Partnerships have become common to gain market shares as evident with the collaboration between Estech Corporation and Terumo Cardiovascular Systems. Terumo has agreed to distribute the products offered by Estech for off-pump and on-pump procedures.
The worldwide coronary bypass graft (CABG) market is projected to reach nearly USD 128 million by 2025. It is projected to expand at a 5.8% CAGR over the forecast period (2014 - 2025). It is driven by increasing cases of CVDs and technologically advanced devices to assist in CABG. On the basis of CABG types, saphenous vein graft surgery is expected to grow at a significant rate over the forecast period.
Endoscopic vein harvesting technique is expected to gain market shares due to reduced complications as compared to conventional vein harvesting. North America can dominate the CABG market throughout the forecast period due to the growing populace and increased healthcare per capita expenditure. Key market players comprise Vitalitec, MAQUET Holding B.V. & Co.KG, Terumo Corporation, and Medtronic.
Read More: http://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-cabg-market
No comments:
Post a Comment